The Valley Desk

ArticleBloodPublished

Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Blood
Published
Subject terms
T-Lymphocytes; Cell Line, Tumor; Animals; Humans; Mice; Mice, SCID; Multiple Myeloma; Receptors, G-Protein-Coupled; Antibodies, Bispecific; Xenograft Model Antitumor Assays; B-Cell Maturation Antigen; CD3 Complex
PubMed ID
41100731
PubMed Central ID
PMC13000934
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal